tiprankstipranks
Precision BioSciences (DTIL)
NASDAQ:DTIL
US Market
DTIL
Precision BioSciences
RESEARCH TOOLSreports

Precision BioSciences (DTIL) Financial Statements

800 Followers

Precision BioSciences Financial Overview

Precision BioSciences's market cap is currently $140.69M. The company's EPS TTM is $1.05; its P/E ratio is -1.14; Precision BioSciences is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 34.26M$ 68.70M$ 48.73M$ 25.10M$ 115.53M
Gross Profit$ 31.51M$ 68.70M$ 48.73M$ 25.10M$ 115.53M
Operating Income$ -52.15M$ -26.16M$ -43.74M$ -62.31M$ -39.38M
EBITDA$ -49.40M$ 13.53M$ -32.04M$ -62.79M$ -20.27M
Net Income$ -46.61M$ 7.17M$ -61.32M$ -111.64M$ -30.60M
Balance Sheet
Cash & Short-Term Investments$ 115.58M$ 86.31M$ 116.68M$ 189.58M$ 143.66M
Total Assets$ 154.42M$ 136.39M$ 159.78M$ 238.17M$ 211.50M
Total Debt$ 28.81M$ 30.05M$ 31.27M$ 24.96M$ 9.11M
Net Debt$ -82.02M$ -55.85M$ -85.41M$ -164.62M$ -134.55M
Total Liabilities$ 62.17M$ 80.00M$ 140.92M$ 177.74M$ 120.33M
Stockholders' Equity$ 92.25M$ 56.39M$ 18.86M$ 60.43M$ 91.17M
Cash Flow
Free Cash Flow$ -65.93M$ -58.70M$ -86.39M$ -49.07M$ -16.66M
Operating Cash Flow$ -65.84M$ -58.45M$ -84.11M$ -45.75M$ -10.85M
Investing Cash Flow$ -634.00K$ -215.00K$ 5.83M$ -3.32M$ -5.80M
Financing Cash Flow$ 95.16M$ 50.45M$ 5.39M$ 94.98M$ 70.52M
Currency in USD

Precision BioSciences Earnings and Revenue History

Income Statement >

Precision BioSciences Debt to Assets

Balance Sheet >

Precision BioSciences Cash Flow

Cash Flow >

Precision BioSciences Forecast EPS vs Actual EPS

Earnings >